vs

Side-by-side financial comparison of NATURAL RESOURCE PARTNERS LP (NRP) and PUMA BIOTECHNOLOGY, INC. (PBYI). Click either name above to swap in a different company.

PUMA BIOTECHNOLOGY, INC. is the larger business by last-quarter revenue ($75.5M vs $51.3M, roughly 1.5× NATURAL RESOURCE PARTNERS LP). On growth, PUMA BIOTECHNOLOGY, INC. posted the faster year-over-year revenue change (27.7% vs -21.8%). Over the past eight quarters, PUMA BIOTECHNOLOGY, INC.'s revenue compounded faster (31.3% CAGR vs -8.3%).

Natural Resource Partners LP is a U.S.-headquartered master limited partnership that owns, manages and leases mineral reserve interests. Its asset portfolio covers coal, aggregates, industrial minerals and oil & gas, with operations primarily across North America, deriving most revenue from royalties paid by third-party resource extraction operators.

Puma Biotechnology is a publicly traded biopharmaceutical company headquartered in Los Angeles, CA.

NRP vs PBYI — Head-to-Head

Bigger by revenue
PBYI
PBYI
1.5× larger
PBYI
$75.5M
$51.3M
NRP
Growing faster (revenue YoY)
PBYI
PBYI
+49.5% gap
PBYI
27.7%
-21.8%
NRP
Faster 2-yr revenue CAGR
PBYI
PBYI
Annualised
PBYI
31.3%
-8.3%
NRP

Income Statement — Q1 FY2025 vs Q4 FY2025

Metric
NRP
NRP
PBYI
PBYI
Revenue
$51.3M
$75.5M
Net Profit
$40.3M
Gross Margin
69.3%
Operating Margin
83.7%
22.7%
Net Margin
78.5%
Revenue YoY
-21.8%
27.7%
Net Profit YoY
-28.4%
EPS (diluted)
$0.26

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
NRP
NRP
PBYI
PBYI
Q4 25
$75.5M
Q3 25
$54.5M
Q2 25
$52.4M
Q1 25
$51.3M
$46.0M
Q4 24
$61.8M
$59.1M
Q3 24
$50.4M
$80.5M
Q2 24
$54.6M
$47.1M
Q1 24
$65.6M
$43.8M
Net Profit
NRP
NRP
PBYI
PBYI
Q4 25
Q3 25
$8.8M
Q2 25
$5.9M
Q1 25
$40.3M
$3.0M
Q4 24
$42.8M
Q3 24
$38.6M
$20.3M
Q2 24
$46.1M
$-4.5M
Q1 24
$56.2M
$-4.8M
Gross Margin
NRP
NRP
PBYI
PBYI
Q4 25
69.3%
Q3 25
77.7%
Q2 25
76.5%
Q1 25
77.1%
Q4 24
76.4%
Q3 24
63.9%
Q2 24
77.4%
Q1 24
75.5%
Operating Margin
NRP
NRP
PBYI
PBYI
Q4 25
22.7%
Q3 25
17.6%
Q2 25
12.7%
Q1 25
83.7%
8.7%
Q4 24
74.9%
22.6%
Q3 24
84.9%
27.4%
Q2 24
92.3%
-4.6%
Q1 24
91.0%
-5.3%
Net Margin
NRP
NRP
PBYI
PBYI
Q4 25
Q3 25
16.2%
Q2 25
11.2%
Q1 25
78.5%
6.5%
Q4 24
69.2%
Q3 24
76.6%
25.2%
Q2 24
84.4%
-9.6%
Q1 24
85.7%
-11.0%
EPS (diluted)
NRP
NRP
PBYI
PBYI
Q4 25
$0.26
Q3 25
$0.17
Q2 25
$0.12
Q1 25
$0.06
Q4 24
$0.40
Q3 24
$0.41
Q2 24
$-0.09
Q1 24
$-0.10

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
NRP
NRP
PBYI
PBYI
Cash + ST InvestmentsLiquidity on hand
$30.9M
$97.5M
Total DebtLower is stronger
$138.8M
$22.7M
Stockholders' EquityBook value
$130.3M
Total Assets
$772.5M
$216.3M
Debt / EquityLower = less leverage
0.17×

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
NRP
NRP
PBYI
PBYI
Q4 25
$97.5M
Q3 25
$94.4M
Q2 25
$96.0M
Q1 25
$30.9M
$93.2M
Q4 24
$30.4M
$101.0M
Q3 24
$30.9M
$96.7M
Q2 24
$32.3M
$96.8M
Q1 24
$11.0M
$107.2M
Total Debt
NRP
NRP
PBYI
PBYI
Q4 25
$22.7M
Q3 25
$34.0M
Q2 25
$45.3M
Q1 25
$138.8M
$56.7M
Q4 24
$142.1M
$68.0M
Q3 24
$197.4M
$79.3M
Q2 24
$210.3M
$90.7M
Q1 24
$188.8M
$102.0M
Stockholders' Equity
NRP
NRP
PBYI
PBYI
Q4 25
$130.3M
Q3 25
$115.3M
Q2 25
$104.7M
Q1 25
$97.1M
Q4 24
$92.1M
Q3 24
$71.1M
Q2 24
$48.5M
Q1 24
$51.0M
Total Assets
NRP
NRP
PBYI
PBYI
Q4 25
$216.3M
Q3 25
$202.9M
Q2 25
$194.9M
Q1 25
$772.5M
$196.2M
Q4 24
$772.9M
$213.3M
Q3 24
$772.9M
$220.7M
Q2 24
$789.6M
$205.0M
Q1 24
$772.9M
$214.1M
Debt / Equity
NRP
NRP
PBYI
PBYI
Q4 25
0.17×
Q3 25
0.30×
Q2 25
0.43×
Q1 25
0.58×
Q4 24
0.74×
Q3 24
1.12×
Q2 24
1.87×
Q1 24
2.00×

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
NRP
NRP
PBYI
PBYI
Operating Cash FlowLast quarter
$34.4M
$14.4M
Free Cash FlowOCF − Capex
$14.4M
FCF MarginFCF / Revenue
19.1%
Capex IntensityCapex / Revenue
0.0%
Cash ConversionOCF / Net Profit
0.86×
TTM Free Cash FlowTrailing 4 quarters
$41.7M

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
NRP
NRP
PBYI
PBYI
Q4 25
$14.4M
Q3 25
$9.7M
Q2 25
$14.1M
Q1 25
$34.4M
$3.6M
Q4 24
$66.2M
$15.6M
Q3 24
$54.1M
$11.0M
Q2 24
$56.6M
$1.0M
Q1 24
$71.5M
$11.2M
Free Cash Flow
NRP
NRP
PBYI
PBYI
Q4 25
$14.4M
Q3 25
$9.7M
Q2 25
$14.1M
Q1 25
$3.6M
Q4 24
$15.6M
Q3 24
$11.0M
Q2 24
$1.0M
Q1 24
FCF Margin
NRP
NRP
PBYI
PBYI
Q4 25
19.1%
Q3 25
17.7%
Q2 25
26.8%
Q1 25
7.7%
Q4 24
26.4%
Q3 24
13.7%
Q2 24
2.1%
Q1 24
Capex Intensity
NRP
NRP
PBYI
PBYI
Q4 25
0.0%
Q3 25
0.0%
Q2 25
0.0%
Q1 25
0.1%
Q4 24
0.0%
0.0%
Q3 24
0.0%
0.0%
Q2 24
0.0%
0.0%
Q1 24
0.0%
0.0%
Cash Conversion
NRP
NRP
PBYI
PBYI
Q4 25
Q3 25
1.10×
Q2 25
2.41×
Q1 25
0.86×
1.21×
Q4 24
1.55×
Q3 24
1.40×
0.54×
Q2 24
1.23×
Q1 24
1.27×

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Revenue Breakdown by Segment

NRP
NRP

Coal Royalty Revenues$35.5M69%
Soda Ash Segment$4.6M9%
Transportation And Processing Services$4.4M9%
Production Lease Minimum Revenues$2.7M5%
Oil And Gas Royalty Revenues$2.4M5%
Other$1.6M3%

PBYI
PBYI

Segment breakdown not available.

Related Comparisons